Plain-English translation of NCT06474598 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes Mellitus research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a medication called to see if it can help your body preserve and rebuild the insulin-producing cells that type 1 diabetes damages. Researchers believe this medication may work by activating a protein in your body that protects these cells and helps them multiply. The trial will compare three different doses of the medication over 3 months to figure out which dose works best.
Type 1 diabetes damages the cells in your pancreas that make insulin, but some people still have a few of these cells working when they're first diagnosed. This medication might help protect and regrow those remaining cells, potentially reducing how much insulin you need to inject. This trial will help doctors understand if this treatment could become a new option for type 1 diabetes.
You likely qualify if…
You likely don't qualify if…
You will take the study medication by mouth as a tablet once or twice daily for 3 months, depending on which group you're assigned to. You'll wear a continuous glucose monitor throughout the study to track your blood sugar patterns, and the study team will access this data through a secure app. You'll attend several clinic visits for check-ups, blood tests, and to discuss how you're doing on the medication.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Canada